Slight improvement in mood and irritability after antiepileptic drug withdrawal: A controlled study in patients on monotherapy

Epilepsy and Behavior

Volumn 10, Issue 3, 2007, Pages 449-455

  Hessen, Erik ^a   Lossius, Morten I ^a,b   Reinvang, Ivar ^b   Gjerstad, Leif ^b  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Antiepileptic drugs; Behavioral side effects; Carbamazepine; Drug withdrawal; Mood

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; VALPROIC ACID;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; MONOTHERAPY; MOOD; MOOD DISORDER; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SEIZURE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; HUMANS; IRRITABLE MOOD; MALE; MIDDLE AGED; MMPI; MOOD DISORDERS; PSYCHOSES, SUBSTANCE-INDUCED; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34247132940     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2007.01.014     Document Type: Article

References (33)

1. Vermeulen J., and Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 22 (1995) 65-95
2. Meador K.J. Cognitive and behavioural assessments in AED trials. Antiepileptic Drug Dev Adv Neurol 76 (1998) 231-238
3. Baker G.A., and Marson A.G. Cognitive and behavioural assessments in clinical trials: what type of measure?. Epilepsy Res 45 (2001) 163-167
4. Brunbech L., and Sabers A. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy. Drugs 62 (2002) 593-604
5. Cochrane H.C., Marson A.G., Baker G.A., and Chadwick D.W. Neuropsychological outcomes in randomised controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 39 (1998) 1088-1097
6. Hessen E., Lossius M., Reinvang I., and Gjerstad L. Influence of major anti epileptic drugs on attention, reaction time and speed of information processing: results from a randomised, double blind, placebo controlled withdrawal study of seizure-free epilepsy patients on monotherapy. Epilepsia 47 (2006) 2038-2045
7. Miller E.N. California Computerized Assessment Battery (CalCAP) manual (1990), Norland Software, Los Angeles
8. Hessen E, Lossius M, Reinvang I, Gjerstad L. Influence of major anti epileptic drugs on neuropsychological function: results from a randomised, double blind, placebo controlled withdrawal study of seizure-free epilepsy patients on monotherapy. J Int Neuropsychol Soc 2006, in press.
9. Butcher J N., Dahlstrom W.G., Graham J.R., et al. MMPI-2: manual for administration and scoring (1989), Univ. of Minnesota Press, Minneapolis
10. Dodril C.B. Problems in the assessment of cognitive effects of antiepileptic drugs. Epilepsia 33 Suppl. 6 (1992) S29-S32
11. Nelson L.D., Elder J.T., Groot J., et al. Personality testing and epilepsy: comparison of two MMPI-2 correction procedures. Epilepsy Behav 5 (2004) 911-918
12. Dikmen S., Hermann B.P., Wilensky A.J., et al. Validity of the Minnesota Multiphasic Personality Inventory (MMPI) to psychopathology in patients with epilepsy. J Nerv Ment Dis. 171 (1983) 114-122
13. Modrego P.J., Pina M.A., Galindo M., and Minguez J. Study of psychopathology in patients with chronic non-lesional epilepsy: a Minnesota Multiphasic Personality Inventory profile controlled study. Eur Neurol 48 (2002) 80-86
14. Ketter T.A., Post R.M., and Theodore W.H. Positive and negative psychotropic effects of antiepileptic drugs in patients with seizure disorders. Neurology 53 (1999) S52-S66
15. Dalby M.A. Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy. Epilepsia 12 (1971) 325-334
16. Rodin E.A., Rim C.S., Kitano H., et al. A comparison of the effectiveness of primidone versus carbamazepine in epileptic outpatients. J Nerv Ment Dis 163 (1976) 41-46
17. Dodrill C.B., and Troupin A.S. Psychotropic effects of carbamazepine in epilepsy: a double blind comparison with phenytoin. Neurology 27 (1977) 1023-1028
18. Shain R.J., Ward J.W., and Guthrie D. Carbamazepine as anticonvulsant in children. Neurology 27 (1977) 476-480
19. Trimble M.R., and Thompson P.J. Anticonvulsant drugs, cognitive function and behaviour. Epilepsia 24 (1983) 55-63
20. Post R.M., Ketter T.A., Denicoff K., et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 128 (1996) 115-129
21. Sommerbeck K.W., Theilgaard T., Rasmussen K.E., et al. Valproate sodium: evaluation of the so-called psychotropic effect: a controlled study. Epilepsia 18 (1977) 159-167
22. Husain S.B., and Wical B.S. Adverse behavioural effects of valproate in children with complex partial seizures. Epilepsia 39 (1998) 162
23. Landrø N.I., Stiles T.C., and Sletvold H. Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol 14 (2001) 233-240
24. Pardo J.V., Pardo P.J., Humes S.W., and Posner M.I. Neurocognitive dysfunction in antidepressant-free, non elderly patients with unipolar depression: alerting and covert orienting of visuospatial attention. J Affect Disord 92 (2006) 71-78
25. Butcher J.N., Dahlstrom W.G., Graham J.R., et al. MMPI-2-Norwegian edition (2004), Psykologiförlaget AB, Stockholm
26. Greene R.L. The MMPI-2: an interpretive manual (2000), Allyn & Bacon, Boston
27. Bland J.M., and Altman D.G. Multiple significance tests: the Bonferroni method. Br Med J 310 (1995) 170
28. Kwan P., and Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 342 (2000) 314-319
29. Lossius M.I., Stavem K., and Gjerstad L. Predictors for recurrence of epileptic seizures in a general epilepsy population. Seizure 8 (1999) 476-479
30. Souza E.A.P., and Salgado P.C.B. A psychosocial view of anxiety and depression in epilepsy. Epilepsy Behav 8 (2006) 232-238
31. Loring D.W., Meador K.J., and Lee G.P. Determinants of quality of life in epilepsy. Epilepsy Behav 5 (2004) 976-980
32. Reijs R, Aldenkamp AP, Krom MD. Mood effects of antiepileptic drugs. Epilepsy Behav 2004;5:66-76.
33. Fenwick P.B.C. Antiepileptic drugs and their psychotropic effects. Epilepsia 3 (1992) 33-36